Both in Surgical Instruments
Neuropace vs Delcath Systems
Over the past year NPCE returned +32.6% and DCTH returned +51.7%; their daily moves had a correlation of 0.22.
NPCE +32.6% DCTH +51.7%Growth of $1, one year, split-adjusted
| Metric | NPCE | DCTH |
|---|---|---|
| Price | $12.46 | $14.44 |
| Market cap | $427.7M | $501.1M |
| Today | +0.97% | +1.05% |
| 1 month | −5.7% | −9.0% |
| 6 months | −26.9% | +25.2% |
| Year to date | −19.3% | +43.0% |
| 1 year | +25.4% | +46.9% |
| Revenue growth (YoY) | +17.1% | +20.6% |
| Gross margin | 82.8% | 89.8% |
| Net margin | −27.2% | 9.2% |
| P/E (TTM) | — | 941.8× |
| Price / sales | 4.3× | 5.3× |
| Net cash | -$7.3M | $95.9M |
| Dividend yield | — | — |
| Volatility (60d) | 40.2% | 32.9% |
| Short % of float | 3.7% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).